Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results Meeting Abstract
| Authors: | Sternschuss, M.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Goh, A. C.; Cha, E. K.; Donat, S. M.; Hakimi, A. A.; Matulewicz, R.; Funt, S. A.; Bajorin, D. F.; Iyer, G.; Ostrovnaya, I.; Al-Ahmadie, H. A.; Rosenberg, J. E.; Coleman, J.; Teo, M. Y. |
| Abstract Title: | Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results |
| Meeting Title: | 2024 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2024 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-02-01 |
| Language: | English |
| ACCESSION: | WOS:001266676900241 |
| DOI: | 10.1200/JCO.2024.42.4_suppl.645 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 645 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
